Bibliography
- CAIRNS R, PAPANDREOU I, DENKO N: Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol. Cancer Res. (2006) 4:61-70.
- SCOZZAFAVA A, MASTROLORENZO A, SUPURAN CT: Carbonic anhydrase inhibitors and activators and their use in therapy. Expert Opin. Ther. Patents (2006) 16(12):1627-1664.
- PASTOREKOVA S, PARKKILA S, ZAVADA J: Tumor-associated carbonic anhydrases and their clinical significance. Adv. Clin. Chem. (2006) 42:167-216.
- SVASTOVA E, HULIKOVA A, RAFAJOVA M et al.: Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. (2004) 577:439-445.
- PASTOREKOVA S, KOPACEK J, PASTOREK J: Carbonic anhydrase inhibitors and the management of cancer. Curr. Top. Med. Chem. (2007) 7:865-878.
- THIRY A, DOGNE JM, MASEREEL B, SUPURAN CT: Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends Pharmacol. Sci. (2006) 27:566-573.
- WINUM JY, RAMI M, SCOZZAFA A, MONTERO JL, SUPURAN CT: Carbonic anhydrase IX: a new druggable target for the design of antitumor agents. Med. Res. Rev. (2007) (In Press).
- CECCHI A, HULIKOVA A, PASTOREK J et al.: Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors. J. Med. Chem. (2005) 48:4834-4841.
Patent
- BAYER HEALTHCARE: WO2004048544 (2004).